Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system

BackgroundArrhythmias are prevalent cardiac disorders with significant impacts on patient quality of life and mortality. Amiodarone, a class III antiarrhythmic agent, is widely used to manage both atrial and ventricular arrhythmias due to its efficacy in prolonging the cardiac action potential and i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jingrong Yang, Mengfan You, Jingxin Wang, Rongfei Sun, Lili Han, Xiaonan Liu, Kaibin Niu, Kaidi Xing, Juanping Sun, Wenge Su, Yifei Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	amiodarone oral intravenous FDA adverse events
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1517616/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system

Similar Items